Skip to main content
Clinical Trials/EUCTR2018-002829-33-NL
EUCTR2018-002829-33-NL
Active, not recruiting
Phase 1

Memory reconsolidation: a new treatment approach towards nicotine addiction. - nl#no_nic

TNO0 sites30 target enrollmentOctober 16, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
nicotine addiction
Sponsor
TNO
Enrollment
30
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 16, 2018
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
TNO

Eligibility Criteria

Inclusion Criteria

  • \- aged between 18 and 65 years;
  • \- smoking 10 or more cigarettes per day for at least 12 months;
  • \- written approval of participant's own general practitioner for participation.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 30
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • \- cardiovasculaire diseases or irregular heartbeat;
  • \- hypotension or hypertension;
  • \- pregnancy or breastfeeding;
  • \- epilepsy;
  • \- current state of asthma or COPD, which necessitates medication use.

Outcomes

Primary Outcomes

Not specified

Similar Trials